These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33835011)

  • 1. Water avoidance and modification of exit-site care with stoma bag results in reduced exit-site infection rate in peritoneal dialysis patients.
    Soetendorp H; Kliuk-Ben Bassat O; Wasserman A; Schwartz D; Bedbalayev R; Faukman I; Grupper A
    Clin Nephrol; 2021 Jun; 95(6):323-331. PubMed ID: 33835011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
    van Diepen AT; Tomlinson GA; Jassal SV
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
    Sachar M; Shah A
    Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
    Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.
    Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG
    Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exit site infections: systematic microbiologic and quality control are needed.
    Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.